ABSTRACT -Background: Clinical and experimental evidence suggests that chronic obstructive pulmonary disease (COPD) is associated with a variety of mental symptoms that range from cognitive slowing to mental confusion and dementia. Purpose: To test the hypothesis that COPD leads to cognitive impairment in the absence of acute confusion or dementia. Method: The global cognitive status of 30 patients with COPD without dementia or acute confusion and 34 controls was assessed with a Brazilian version of the Mini-Mental State Exam (MMSE). Results: The MMSE scores were significantly lower in the patient group and inversely related to the severity of COPD. This finding could not be attributed to age, education, gender, daytime sleepiness, hypoxemia, chronic tobacco use, or associated diseases such as diabetes, depression, high blood pressure or alcoholism. Conclusion: These results suggest the existence of a subclinical encephalopathy of COPD characterized by a subtle impairment of global cognitive ability.
The neurological manifestations of hypercapnic respiratory disease were fi rst described as a collection of manifestations consisting of headache, papilledema, fatigue, confusion and asterixis, eventually progressing to stupor and coma 1 . This clinical worsening is paralleled by a progressive slowing of the basic frequencies of the scalp electroencephalogram. Pathophysiologically the manifestations of hypercapnic respiratory disease refl ect a progressive reduction of the alveolar surface of gas exchange, with respiratory acidosis and a concomitant retention of arterial CO 2 . The critical role of CO 2 retention in the pathophysiology of headache and papilledema (the pseudotumor syndrome), as well as of muscle twitching, sleepiness and confusion (the syndrome of metabolic encephalopathy), is emphasized in the designation of this symptom-complex as "CO 2 narcosis" 2 .
In contrast to what is usually observed in advanced or unstable chronic obstructive pulmonary disease (COPD), the cognitive status of clinically stable patients has been comparatively less studied. Because such patients are awake and oriented they may convey a cursory impression that they are cognitively intact. However, indirect evidence suggests that this may not be accurate, at least in some cases. Several reports indicate that a mild encephalopathy is a fairly common occurrence in hepatic, thyroid and renal disease [3] [4] [5] [6] . Because these milder cognitive chang-es do not cross the diagnostic threshold for a formal diagnosis of acute confusional state or dementia 7 , the expression "subclinical", or "subthreshold" encephalopathy has been employed as a shorthand reference. The subclinical encephalopathy of these conditions is characterized by mental slowing with a preserved global cognitive status. In particular, temporal and spatial orientation is, as a rule, entirely normal, yet some degree of cerebral impairment of a magnitude suffi cient to compromise routine activities may still be detected by sensitive tests.
The aim of the present investigation was to test the hypothesis that clinically stable patients with COPD without overt cognitive symptoms may nevertheless present subtle cognitive impairments.
METHOD
Twenty men and 10 women with COPD and 34 controls (10 men and 24 women) without respiratory disease participated in the study as nonpaid volunteers after providing written informed consent. Between 2000 and 2006 patients with a clinical and spirometric diagnosis of COPD [8] [9] [10] were recruited from the outpatient sector of the Service of Respiratory and Lung Diseases of the Gaffrée e Guinle University Hospital (HUGG). They were clinically stable, normally engaged in their routine daily life activities, and had not been admitted to a hospital or treated with antibiotics in the preceding 30 days. These criteria selected only those patients who were in an optimal clinical condition during a relatively protracted period of stability, thus excluding patients with unstable disease. The control group was composed of hospital employees and acquaintances of the authors without a history or current clinical evidence of chronic respiratory disease. All medications currently in use, as well as red blood cell counts, blood glucose, blood urea nitrogen, blood pressure levels, and drinking habits were noted in each case. The study did not receive funding from research agencies and was conducted in the HUGG as part of the post-doctoral project of one of the authors (OMPL). The project was approved by Ethics Committee of the HUGG and the National Council of Education and Research (CONEPE). Cognitive, behavioral and socio-occupational measures -The Mini-Mental State Exam (MMSE) was used to gauge the global cognitive status as well as to ascertain that no participant was either demented or confused 11 . From 2003 to the present we adopted the offi cial Brazilian version of the instrument 12 . Dementia, Acute Confusional State (Delirium) and Depression were diagnosed following the criteria of the American Psychiatric Association 13 and depression was additionally staged with the Beck Depression Inventory 14 . Daytime somnolence was assessed with the Epworth Sleepiness Scale 15 . Alcohol abuse was assessed with the CAGE questionnaire 16 . The cumulative cigarette consumption (number of cigarettes smoked during a lifetime) was estimated based on the number of smoking years and the yearly tobacco consumption. The overall socio-occupational level was assessed with the Global Assessment of Functioning (GAF) Scale 13 . 17 -All results are expressed as means and standard deviations (x±sd). The signifi cance of differences between means was assessed with analyses of variance (ANOVA). Associations between dimensional and categorical variables of interest were evaluated, respectively, with the Pearson correlation coeffi cient (r) and with the χ² test. A two-tailed critical value (α) of 0.05 was adopted as a signifi cance threshold for all statistical tests. The effect size and statistical power of statistical tests of interest were calculated with G*Power 18 .
Statistical analyses

RESULTS
The results are summarized in the Table. No significant differences were found between groups in relation to age (p>0.89), education (p>0.33), regular alcohol consumption (p>0.77), depression (p>0.07), and systolic (p>0.12) or diastolic (p>0.26) arterial blood pressure. However, there were more women among controls than among patients (p=0.01). As expected, there were more smokers in the patient group (p<0.001). The MMSE scores were signifi cantly lower in patients than in controls (p<0.001) and inversely related to the severity of COPD (r= -0.49, p<0.001). Socio-occupational functioning was also inversely related to the severity of COPD (r= -0.47, p<0.001) and positively related to the MMSE scores (r=0.41, p<0.01). The statistical power (β) and effect size (d) of the mean difference between groups on MMSE performance were, respectively 0.95 ("high") and 0.74 ("medium to large").
DISCUSSION
The main findings of the present investigation can be summarized as follows: (i) patients with clinically stable COPD without dementia or acute confusion may nonetheless show global cognitive impairment, as revealed by comparatively lower scores on the MMSE, (ii) the MMSE was inversely related to the severity of COPD, and (iii) this cognitive impairment was not due to age, education, daytime sleepiness, hypoxemia, tobacco consumption, and associated diseases such as diabetes, depression, high blood pressure, and alcoholism.
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These fi ndings acquire additional relevance for the following reasons. Firstly, given the relatively low sensitivity of the MMSE, it is surprising that any differences in cognitive status between groups were noted at all. One implication of this fi nding is that the global cognitive level of our patients may in fact have been lower than it would be if they did not suffer from COPD. This decline is subtle and may easily pass unnoticed in routine consultations. Secondly, further studies are necessary to verify whether this relative decline has a direct adverse infl uence on daily life, because, if it does, cognitive status may be an independent target for treatment. Indirect evidence in favor of this possibility was the verifi cation of signifi cant associations between MMSE, COPD, and GAF scores.
Our study has several limitations that can be tackled in future research. The ease of administration of the MMSE is counterbalanced by its relative lack of sensibility and specifi city. For example, studies addressing specifi c cognitive domains (such as executive performance, attention, cognitive speed) might give important clues on which cognitive processes best explain the performance of our patients on the MMSE. Some studies do indicate that patients with COPD present memory impairment, and this could explain at least in part the decline in the MMSE [19] [20] [21] [22] [23] [24] [25] . However, the different clinical characteristics of our patients and of the patients of the aforementioned studies preclude direct comparisons. Another limitation was the lack of arterial measures of paCO 2 and paO 2 , which would allow more stringent conclusions on the mechanisms by which cognition fails in such cases.
Regardless the exact pathophysiological mechanisms at play our results support the proposal that a subclinical encephalopathy may indeed exist in at least a few cases of COPD. As far as we are aware, the concept of subclinical encephalopathy has not as yet been explicitly extended to COPD. The results of the present study, although admittedly preliminary, suggest that the concept of subclinical encephalopathy might be extended to patients with COPD. This idea would gain further support if such patients were C ("Cutting down") A ("Annoyance") G ("Guilty") E ("Eye-openers").
shown to perform slower than controls on measures of psychomotor speed, a hypothesis currently under study by our group.
